BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16601520)

  • 1. The impact of screening for asymptomatic myocardial ischemia in individuals with type 2 diabetes.
    Chyun DA; Katten DM; Melkus GD; Talley S; Davey JA; Wackers FJ
    J Cardiovasc Nurs; 2006; 21(2):E1-7. PubMed ID: 16601520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of psychological factors, physical activity, neuropathy, and quality of life in type 2 diabetes.
    Chyun DA; Melkus GD; Katten DM; Price WJ; Davey JA; Grey N; Heller G; Wackers FJ
    Biol Res Nurs; 2006 Apr; 7(4):279-88. PubMed ID: 16581898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A risk score to predict silent myocardial ischemia in patients with coronary artery disease under aspirin therapy presenting with upper gastrointestinal hemorrhage.
    Chen CC; Chong CF; Kuo CD; Wang TL
    Am J Emerg Med; 2007 May; 25(4):406-13. PubMed ID: 17499658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: is it appropriate and cost-effective?
    Beller GA
    J Am Coll Cardiol; 2007 May; 49(19):1918-23. PubMed ID: 17498575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are illness perceptions about coronary artery disease predictive of depression and quality of life outcomes?
    Stafford L; Berk M; Jackson HJ
    J Psychosom Res; 2009 Mar; 66(3):211-20. PubMed ID: 19232233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial outcomes of Hong Kong Chinese diagnosed with acute coronary syndromes: a prospective repeated measures study.
    Chan DS; Chau JP; Chang AM
    Int J Nurs Stud; 2007 Aug; 44(6):945-52. PubMed ID: 16697383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.
    Hayashino Y; Shimbo T; Tsujii S; Ishii H; Kondo H; Nakamura T; Nagata-Kobayashi S; Fukui T
    Int J Cardiol; 2007 May; 118(1):88-96. PubMed ID: 16949690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial factors contributing to persistent depressive symptoms in type 2 diabetic patients: a Croatian survey from the European Depression in Diabetes Research Consortium.
    Pibernik-Okanovic M; Begic D; Peros K; Szabo S; Metelko Z;
    J Diabetes Complications; 2008; 22(4):246-53. PubMed ID: 18413168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of coronary risk factors and quality of life in coronary artery disease patients with versus without diabetes mellitus.
    Pischke CR; Weidner G; Elliott-Eller M; Scherwitz L; Merritt-Worden TA; Marlin R; Lipsenthal L; Finkel R; Saunders D; McCormac P; Scheer JM; Collins RE; Guarneri EM; Ornish D
    Am J Cardiol; 2006 May; 97(9):1267-73. PubMed ID: 16635593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort.
    Taylor AJ; Bindeman J; Feuerstein I; Le T; Bauer K; Byrd C; Wu H; O'Malley PG
    J Am Coll Cardiol; 2008 Apr; 51(14):1337-41. PubMed ID: 18387433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes? The ADDITION Study, Denmark.
    Mai KS; Sandbaek A; Borch-Johnsen K; Lauritzen T
    Diabet Med; 2007 Oct; 24(10):1121-8. PubMed ID: 17725631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM
    Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
    Katerinis I; Nguyen QV; Magnin JL; Descombes E
    Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cardiovascular outcomes following ischemic heart disease in patients with and without peripheral vascular disease.
    Nakata S; Yokoi Y; Matsumoto R; Shirai N; Otsuka R; Sugioka K; Yoshitani H; Ehara S; Kataoka T; Yoshiyama M
    Osaka City Med J; 2008 Jun; 54(1):21-30. PubMed ID: 18819262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes.
    Clarke PM; Hayes AJ; Glasziou PG; Scott R; Simes J; Keech AC
    Med Care; 2009 Jan; 47(1):61-8. PubMed ID: 19106732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance study for creating the national clinical database relating to ECG-gated myocardial perfusion SPECT of asymptomatic ischemic heart disease in patients with type-2 diabetes mellitus: J-ACCESS 2 study design.
    Kusuoka H; Yamasaki Y; Izumi T; Kashiwagi A; Kawamori R; Shimamoto K; Yamada N; Nishimura T
    Ann Nucl Med; 2008 Jan; 22(1):13-21. PubMed ID: 18250983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological outcomes of patients with screen-detected type 2 diabetes: the influence of time since diagnosis and treatment intensity.
    Thoolen BJ; de Ridder DT; Bensing JM; Gorter KJ; Rutten GE
    Diabetes Care; 2006 Oct; 29(10):2257-62. PubMed ID: 17003303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported predictors of depressive symptomatology in an elderly population with type 2 diabetes mellitus: a prospective cohort study.
    Pawaskar MD; Anderson RT; Balkrishnan R
    Health Qual Life Outcomes; 2007 Aug; 5():50. PubMed ID: 17683531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
    Pedersen SS; Denollet J; Ong AT; Sonnenschein K; Erdman RA; Serruys PW; van Domburg RT
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the "Matthew Effect" on the motivation and ability to make lifestyle changes in 217 heart rehabilitation patients.
    Mildestvedt T; Meland E
    Scand J Public Health; 2007; 35(2):140-7. PubMed ID: 17454917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.